These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12676791)

  • 1. G-CSF as immune regulator in T cells expressing the G-CSF receptor: implications for transplantation and autoimmune diseases.
    Franzke A; Piao W; Lauber J; Gatzlaff P; Könecke C; Hansen W; Schmitt-Thomsen A; Hertenstein B; Buer J; Ganser A
    Blood; 2003 Jul; 102(2):734-9. PubMed ID: 12676791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants.
    Volpi I; Perruccio K; Tosti A; Capanni M; Ruggeri L; Posati S; Aversa F; Tabilio A; Romani L; Martelli MF; Velardi A
    Blood; 2001 Apr; 97(8):2514-21. PubMed ID: 11290617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells.
    Arpinati M; Green CL; Heimfeld S; Heuser JE; Anasetti C
    Blood; 2000 Apr; 95(8):2484-90. PubMed ID: 10753825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the phenotype, cytokine gene expression profiles, and in vivo alloreactivity of T cells mobilized with plerixafor compared with G-CSF.
    Lundqvist A; Smith AL; Takahashi Y; Wong S; Bahceci E; Cook L; Ramos C; Tawab A; McCoy JP; Read EJ; Khuu HM; Bolan CD; Joo J; Geller N; Leitman SF; Calandra G; Dunbar C; Kurlander R; Childs RW
    J Immunol; 2013 Dec; 191(12):6241-9. PubMed ID: 24244025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo.
    Sloand EM; Kim S; Maciejewski JP; Van Rhee F; Chaudhuri A; Barrett J; Young NS
    Blood; 2000 Apr; 95(7):2269-74. PubMed ID: 10733495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintaining hyporesponsiveness and polarization potential of T cells after in vitro mixture of G-CSF mobilized peripheral blood grafts and G-CSF primed bone marrow grafts in different proportions.
    Huang XJ; Chang YJ; Zhao XY
    Transpl Immunol; 2007 Apr; 17(3):193-7. PubMed ID: 17331846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte colony-stimulating factor decreases the Th1/Th2 ratio in peripheral blood mononuclear cells from patients with chronic immune thrombocytopenic purpura in vitro.
    Ge F; Zhang Z; Hou J; Cao F; Zhang Y; Wang P; Wei H; Zhou J
    Thromb Res; 2016 Dec; 148():76-84. PubMed ID: 27815970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enforced expression of GATA-3 in transgenic mice inhibits Th1 differentiation and induces the formation of a T1/ST2-expressing Th2-committed T cell compartment in vivo.
    Nawijn MC; Dingjan GM; Ferreira R; Lambrecht BN; Karis A; Grosveld F; Savelkoul H; Hendriks RW
    J Immunol; 2001 Jul; 167(2):724-32. PubMed ID: 11441076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G-CSF reduces IFN-gamma and IL-4 production by T cells after allogeneic stimulation by indirectly modulating monocyte function.
    Nawa Y; Teshima T; Sunami K; Hiramatsu Y; Maeda Y; Yano T; Shinagawa K; Ishimaru F; Omoto E; Harada M
    Bone Marrow Transplant; 2000 May; 25(10):1035-40. PubMed ID: 10828862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory γδ T cells induced by G-CSF participate in acute graft-versus-host disease regulation in G-CSF-mobilized allogeneic peripheral blood stem cell transplantation.
    Xuan L; Wu X; Qiu D; Gao L; Liu H; Fan Z; Huang F; Jin Z; Sun J; Li Y; Liu Q
    J Transl Med; 2018 May; 16(1):144. PubMed ID: 29801459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G-CSF induces a potentially tolerant gene and immunophenotype profile in T cells in vivo.
    Toh HC; Sun L; Soe Y; Wu Y; Phoon YP; Chia WK; Wu J; Wong KY; Tan P
    Clin Immunol; 2009 Jul; 132(1):83-92. PubMed ID: 19345152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral Blood Stem Cell Mobilization in Healthy Donors by Granulocyte Colony-Stimulating Factor Causes Preferential Mobilization of Lymphocyte Subsets.
    Melve GK; Ersvaer E; Eide GE; Kristoffersen EK; Bruserud Ø
    Front Immunol; 2018; 9():845. PubMed ID: 29770133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor.
    Jun HX; Jun CY; Yu ZX
    Haematologica; 2004 Dec; 89(12):1517-24. PubMed ID: 15590404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation.
    MacDonald KP; Rowe V; Filippich C; Thomas R; Clouston AD; Welply JK; Hart DN; Ferrara JL; Hill GR
    Blood; 2003 Mar; 101(5):2033-42. PubMed ID: 12393418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of granulocyte colony-stimulating factor mobilization on the expression patterns, clonality and signal transduction of TRAV and TRBV repertoire.
    Xuan L; Wu X; Wu M; Zhang Y; Liu H; Fan Z; Sun J; Liu Q
    Immunobiology; 2012 Aug; 217(8):816-22. PubMed ID: 22658922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial.
    Lonial S; Akhtari M; Kaufman J; Torre C; Lechowicz MJ; Flowers C; Sinha R; Khoury HJ; Langston AA; Waller EK
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):460-7. PubMed ID: 23201472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of CCR5 and CCR7 expression on donor peripheral blood T cell subsets after mobilization with rhG-CSF correlate with acute graft-versus-host disease.
    Wang M; Hu J; Qiu ZX; Liu W; Wang MJ; Li Y; Sun YH; Zhu SN; Ren HY; Dong YJ
    Clin Immunol; 2018 Jun; 191():81-87. PubMed ID: 28965881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic graft-versus-host disease after granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation: the role of donor T-cell dose and differentiation.
    MacDonald KP; Rowe V; Filippich C; Johnson D; Morris ES; Clouston AD; Ferrara JL; Hill GR
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):373-85. PubMed ID: 15148491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cells.
    Tayebi H; Kuttler F; Saas P; Lienard A; Petracca B; Lapierre V; Ferrand C; Fest T; Cahn J; Blaise D; Kuentz M; Hervé P; Tiberghien P; Robinet E
    Exp Hematol; 2001 Apr; 29(4):458-70. PubMed ID: 11301186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia.
    Drach D; Estrov Z; Zhao S; Drach J; Cork A; Collins D; Kantarjian H; Andreeff M
    Leuk Lymphoma; 1994 Dec; 16(1-2):79-88. PubMed ID: 7535143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.